ActivePhase 3ACTRN12605000239662

The value of an advance notification letter prior to a postal offer of bowel cancer screening on population participation in screening.


Sponsor

Prof. Graeme Young MD, FRACP

Enrollment

1,200 participants

Start Date

Jan 1, 2005

Study Type

Interventional

Conditions

Summary

Improved participation in screening for bowel cancer is desirable. Currently population scale bowel cancer screening program delivery is by mailed offer, without prior warning, from a central screening service and invitations include a occult blood kit. Invitees may reject this process as they are unprepared to receive such an offer. One approach is to improve communication between screening providers and invitees through improved population scale interpersonal contact. We have developed a preliminary letter to precede an postal invitation to bowel cancer screening. The letter simply informs invitees that they will soon receive a screening invitation and provides them with some basic information about bowel cancer screening. We will randomly select invitees from the electoral roll and compare population screening participation between groups with or without the preliminary letter to determine which program results in the greater participation rate. Improved participation in screening will ultimately reduce deaths from bowel cancer


Eligibility

Sex: Both males and femalesMin Age: 50 YearssMax Age: 74 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying the value of an advance notification letter prior to a postal offer of bowel cancer screening on population participation in screening. You may be eligible if you are adults aged 50 to 74. People with people already participating in bowel cancer screening research and service programs coordinated from the bowel health service may not be able to participate. Participation may involve medical tests, study visits, and follow-up appointments.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

A bowel cancer screening program that incorporates a preliminary letter to notify an invitee that they will be shortly sent an invitation to participate.

A bowel cancer screening program that incorporates a preliminary letter to notify an invitee that they will be shortly sent an invitation to participate.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000239662